Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Anabolic-androgenic steroids can harm women's health and their offspring.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Uterine transplants for transgender women are feasible but need more research.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

PCOS affects many women and requires early detection and symptom management.

The risks of testosterone implants in women outweigh the benefits.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

PCOS is common among Indian women, often with metabolic issues, needing better management strategies.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

A young woman developed a vision-threatening eye condition after using minoxidil for hair loss, which improved when she stopped the medication.